Quotient Sciences has been recognized with multiple 2022 CRO Leadership Awards, including two Champion Awards. The CRO Leadership Awards recognizes top performing outsourcing organizations in the drug development space. Quotient received leadership awards in all five categories, which included: Capabilities, Compatibility, Expertise, Reliability, Quality in the Overall award segment. Quotient was also honored with two champion awards in Expertise and Reliability. Champion awards are given to companies that scored one standard deviation more above the weighted average in each of the categories and are deemed “top performers”.
Champion Award Winning Categories:
- Expertise (Overall)
- Reliability (Overall)
Leadership Award Winning Categories:
- Capabilities (Overall)
- Compatibility (Overall)
- Expertise (Overall)
- Reliability (Overall)
- Quality (Overall)
For the 2022 CRO Leadership Awards, we once again teamed up with ISR Reports to determine the award recipients. 50 contract research organizations were assessed on 20+ performance metrics in ISR’s annual CRO Quality Benchmarking survey. Respondents only evaluate companies with which they have worked on an outsourced project within the past 18 months. This level of qualification ensures that survey responses are based on actual involvement with CROs and clear experiential data.